Answers are grounded in this paper and cite their sources.
Metabolic syndrome (MetS) and elevated C-peptide both reflect insulin resistance and increased cardiometabolic risk. We assessed whether fasting serum C-peptide can serve as an indicator of MetS in non-diabetic adults from the general population. We analyzed 4,072 adults aged 20–74 years without diabetes from a predominantly white Caucasian population participating in the Healthy Finland 2023 health examination survey. We evaluated the ability of C-peptide to discriminate MetS using receiver operating characteristic (ROC) analyses and identified optimal cut-offs using the Youden index. We compared C-peptide with glycated hemoglobin (HbA1c), high-sensitivity C-reactive protein (hs-CRP), and alanine aminotransferase (ALT), and examined performance separately in obese and non-obese participants. In the full sample, C-peptide discriminated MetS well, with AUCs of 0.80–0.81 across sexes and MetS definitions. Using the International Diabetes Federation (IDF) definition, optimal cut-offs were ≥ 0.66 nmol/L for men and ≥ 0.63 nmol/L for women (sensitivities 72% and 70%; specificities 75% and 76%). C-peptide outperformed HbA1c, ALT, and hs-CRP ( p < 0.05), suggesting its potential as a simple biomarker for early identification of MetS. Discrimination was modestly lower in non-obese participants (AUCs 0.75–0.77 across definitions) and further attenuated in obese participants (AUC 0.73–0.75 across definitions). C-peptide remained the best-performing marker in non-obese participants, whereas among obese participants its performance was comparable to HbA1c. The optimal cut-offs yielded high negative predictive values (84–87%) among non-obese participants, whereas positive predictive values were highest (79–90%) among obese participants. Fasting C-peptide is a promising screening indicator of MetS in non-diabetic adults. It outperformed several commonly used biomarkers and showed good discrimination across sexes and MetS definitions, although further studies are needed to establish its role in clinical practice.
No takes yet. Share an insight, caveat, or question.
Mustelin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: